📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial (2024)

First Author: Alagaratnam J

Attributed to: Viral Pathogens funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jve.2024.100381

Publication URI: http://dx.doi.org/10.1016/j.jve.2024.100381

Type: Journal Article/Review

Parent Publication: Journal of Virus Eradication

Issue: 2